Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QAV680 vs placebo in mild to moderate persistent asthma (cross-over, steroid-free)
2008-005168-15Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of QAV680 in asthma (2 arms), sponsored by Novartis. Started Sep 2008; status: completed.
02
Drugs
QAV680
03
Conditions
asthma
Beyond the preview
Go deeper on 2008-005168-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005168-15.